CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy: The decrease of anti-CNTN1 antibody levels along with improved CIDP by immunotherapy and staining of the paranodes by the patient's sera suggest a pathogenic role of anti-CNTN1 antibodies.